A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
Completed · Phase 2 · Has a placebo group
Conditions studied: Chronic Spontaneous Urticaria
In brief
The purpose of this study is to assess the clinical effect, the pharmacodynamics, the safety, and the pharmacokinetics of barzolvolimab (CDX-0159) in patients with Chronic Spontaneous Urticaria
Key facts
- Study ID
- NCT05368285
- Run by
- Celldex Therapeutics
- People needed
- 208
- Starts
- 2022-05-19
- Expected to finish
- 2024-12-20
- Last updated by the study team
- 2025-03-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Medical Research of Arizona — Scottsdale, Arizona, United States
- Little Rock Allergy & Asthma CRC — Little Rock, Arkansas, United States
- Kern Research, Inc — Bakersfield, California, United States
- Allergy & Asthma Consultants — Redwood City, California, United States
- IMMUNOe Research Centers — Centennial, Colorado, United States
- Treasure Valley Medical Research — Boise, Idaho, United States
- Allergy & Asthma Specialists, PSC — Owensboro, Kentucky, United States
- Institute for Asthma and Allergy — Chevy Chase, Maryland, United States
- Chesapeake Clinical Research — White Marsh, Maryland, United States
- Respiratory Medicine Research Institute of Michigan, PLC — Ypsilanti, Michigan, United States
- University of Nebraska Medical Center — Omaha, Nebraska, United States
- Montefiore Medical Center/Subspeciality-Allergy and Immunology — The Bronx, New York, United States
- "Diagnostic Consultative Center Pulmed" EOOD — Plovdiv, Bulgaria
- University Multiprofile Hospital for Active Treatment "Sveti Georgi" EAD — Plovdiv, Bulgaria
- Outpatient clinic for individual practice for specialized outpatient medical care in allergology-Doctor Thalat Sally Cholak EOOD — Razgrad, Bulgaria
- Medical Center Iskar EOOD Office of Clinical Allergology — Sofia, Bulgaria
- Medical Center "SYNEXUS SOFIA", EOOD — Sofia, Bulgaria
- Vahlberg & Pild Clinic — Tallinn, Estonia
- Healthy Future — Tbilisi, Georgia
- Center of Allergy and Immunology — Tbilisi, Georgia
- Multiprofile Clinic Consilium Medulla — Tbilisi, Georgia
- LMU Klinikum - Klinik und Poliklinik für Dermatologie und Allergologie DASZ-Dermato-Allergologisches Studien Zentrum — München, Bavaria, Germany
- Universitaetsklinikum Giessen u. Marburg GmbH — Marburg, Hesse, Germany
- Hannover Medical University — Hanover, Lower Saxony, Germany
- Clinical Research Center of Alabama dba Allervie Clinical Research — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.